RE:RE:RE:enough is enoughWell I hope you can get out without a loss and preferably we all end up making some back on our investment. I have a hunch they are not being totally transparent with us; PMN310 goes back to 2018 and as the years go by so does their calendar of bringing it to market which tells me they have no clue what they're doing or the product may not be a slam dunk afterall. For now, I'll give them the benefit of the doubt that most large pharma companies were too busy making vaccines thereby delaying PMN310. Maybe Elliot can pop a few pills to smarten up and get this moving. Furthermore, i don't believe a listing on another exchange is the answer. If they truly have discovered something, it should be attractive on its own merit, and not need a sexy NYSE listing. jmo